ArticleAnnals of medicine and surgery (2012)2026
Posterior reversible encephalopathy syndrome as a rare presentation of systemic lupus erythematosus: a case report.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and importance: Posterior reversible encephalopathy syndrome (PRES) is a rare clinical-radiological entity characterized by the rapid onset of neurological symptoms accompanied by typical radiological signs of vasogenic edema predominantly in the posterior brain region. Numerous causes can contribute to PRES, including hypertension, renal failure, pre-eclampsia, and immunosuppression. Systemic lupus erythematosus (SLE) is a multisystem autoimmune disorder involving several immune dysfunctions and can affect the central nervous system. Although rare, cases of PRES have been documented in individuals diagnosed with SLE. Case presentation: We here describe a case of an 18-year-old female who was newly diagnosed with SLE and experienced generalized tonic and clonic seizures during treatment as an inpatient in the hospital. On further evaluation for the cause of the seizure, the presence of PRES was found in a brain MRI. The patient condition was managed with antiepileptic medication and kept on regular BP monitoring. For the management of SLE, due to infertility risk, the patient was discharged on mycophenolate mofetil. Clinical discussion: PRES is an uncommon but recognized complication in SLE, often triggered by hypertension, immunosuppressive therapy, or disease activity. MRI remains the diagnostic gold standard, revealing characteristic posterior white matter changes. Early recognition and supportive management, including seizure control, can lead to complete recovery and prevent long-term deficits. Conclusion: PRES, though rare in SLE, should be considered in patients with seizures, altered mental status, and visual disturbances with supportive brain imaging. Further research is needed to clarify its mechanisms and improve management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.